Skip to main content
Fig. 4 | Journal of Neuroinflammation

Fig. 4

From: Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy

Fig. 4

Treg cell response following IVIG therapy in GBS patients correlates negatively with effector T cells. a Correlation between the fold changes in circulating Treg cells at week 1 after initiation of IVIG therapy and the fold changes in IFN-γ+ CD4+ T cells at weeks 1, 2, and ≥4. b Correlation between the fold changes in circulating Treg cells at week 1 following initiation of IVIG therapy and the fold changes in TNF-α+ CD4+ T cells at weeks 1, 2, and ≥4. Each symbol represents individual patient. r = Pearson correlation. p = statistical significance

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094